FibroGen Initiates LELANTOS-2 – Second Phase 3 Clinical Study of Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

NEXT STORY
Global GMP Cytokines Market Report 2021: Market is Expected to Reach US$ 158.13 Million in 2027 from US$ 84.72 Million in 2019
PREV STORY
Global $34.5 Billion Dermatology Drugs Market Analysis and Growth Forecast to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Preclinical Data Highlighting Uptake and Enhanced Anti-Tumor Effects of Cellectar’s CLR 131 in Head and Neck Cancer Presented at AACR Annual Meeting

author_avatar
NASDAQ Market News

Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints

author_avatar
NASDAQ Market News

Notable Announces Leadership Team Expansion

author_avatar
NASDAQ Market News